Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
patients who assigned to the intervention group will take 7 times phone calls from case manager
Chungju community health care center
Chungju, ChoongBuk, South Korea
Reduced depression symptoms
HAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up
Time frame: 3 months
Depression response and remissionhealth related quality of life
HAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods. Depression remission is defined by 7 or less of HAMD score at each follow-up periods
Time frame: 3months and 6months
Reduced suicide ideation
SSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods
Time frame: 3 months and 6 months
Improvement of Quality of life
EQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods
Time frame: 3 months and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.